Lyra Therapeutics, Inc.
Board Member, CTO
2023-01-01–2024-06-20
John E. Bishop
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John E. Bishop
John E. Bishop was last confirmed as Board Member at Lyra Therapeutics, Inc. in a filing dated April 29, 2024. Earlier roles on record: CTO at Lyra Therapeutics, Inc. until June 20, 2024. Lyra Therapeutics, Inc. reported in an 8-K filed May 21, 2024 that John E. Bishop was terminated as Chief Technology Officer, effective June 20, 2024. The proxy statement of Lyra Therapeutics, Inc. reports total compensation of $1,030,415 for John E. Bishop in fiscal 2023, including a base salary of $385,000.
“On May 17, 2024, John E. Bishop, Ph.D. was informed that his position was being eliminated in connection with the reduction in force described in Item 2.05 of this Current Report on Form 8-K, effective on or about June 20, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lyra Therapeutics, Inc.
Board Member
Proxy statement
2023-01-01–2024-04-29
Last confirmed by a filing; no departure on record
-
Lyra Therapeutics, Inc.
CTO
Proxy statement
Start not stated–2024-06-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lyra Therapeutics, Inc. | Chief Technology Officer | $385,000 | $1,030,415 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.